Abstract
The practice of polypharmacy has become increasingly prevalent in the treatment of individuals with psychiatric disorders. This has become a controversial issue due to the lack of safety and efficacy studies that would support its use. The purpose of the current study is to evaluate the frequency of polypharmacy in individuals with IDD. It is expected that the individuals with IDD will have a high percentage of poly-pharmaceutical use. Additionally, the present study examines the use of antipsychotic medications in individuals with IDD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
